- Home
- GLO vs ATAI Comparison
GLO vs ATAI Comparison
Compare GLO & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLO
- ATAI
- Stock Information
- Founded
- GLO 2006
- ATAI 2018
- Country
- GLO United States
- ATAI Germany
- Employees
- GLO N/A
- ATAI N/A
- Industry
- GLO Finance/Investors Services
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- GLO Finance
- ATAI Health Care
- Exchange
- GLO Nasdaq
- ATAI Nasdaq
- Market Cap
- GLO 220.1M
- ATAI 214.8M
- IPO Year
- GLO N/A
- ATAI 2021
- Fundamental
- Price
- GLO $5.15
- ATAI $1.24
- Analyst Decision
- GLO
- ATAI Strong Buy
- Analyst Count
- GLO 0
- ATAI 4
- Target Price
- GLO N/A
- ATAI $9.00
- AVG Volume (30 Days)
- GLO 170.5K
- ATAI 1.3M
- Earning Date
- GLO 01-01-0001
- ATAI 11-13-2024
- Dividend Yield
- GLO 11.38%
- ATAI N/A
- EPS Growth
- GLO N/A
- ATAI N/A
- EPS
- GLO N/A
- ATAI N/A
- Revenue
- GLO N/A
- ATAI $331,000.00
- Revenue This Year
- GLO N/A
- ATAI $93.15
- Revenue Next Year
- GLO N/A
- ATAI N/A
- P/E Ratio
- GLO N/A
- ATAI N/A
- Revenue Growth
- GLO N/A
- ATAI N/A
- 52 Week Low
- GLO $4.08
- ATAI $1.03
- 52 Week High
- GLO $5.18
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- GLO 27.44
- ATAI 33.95
- Support Level
- GLO $5.00
- ATAI $1.15
- Resistance Level
- GLO $5.33
- ATAI $1.69
- Average True Range (ATR)
- GLO 0.06
- ATAI 0.11
- MACD
- GLO -0.03
- ATAI -0.06
- Stochastic Oscillator
- GLO 15.23
- ATAI 3.69
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return. The fund invests in a mix of U.S. and non-U.S. equity and debt securities.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.